Company Overview Investor Relations News Our Companies Contact MGT Capital Investments MGT Capital Investments
MGT (AMEX)
$0.06
   + 0.00

 Directors and Officers
 Corporate Governance
 Press Releases
 
Events
 Stock Information
 SEC Filings
 Annual Report & Proxy
 Investor FAQs
 Request Printed Materials
 Contact Us

Medicsight featured in
Aim & Plus Newsletter


Investor Relations

MGT Capital Investments, Inc. is a holding company with investments in Medicsight Ltd.

Investment Highlights

  • Commercialization of medical imaging technologies
  • Targets dynamic & consolidating HCIT sector

Medicsight Ltd

Medicsight LTD is a leading developer of computer-aided detection (CAD) and image analysis software for the medical imaging market. The CAD software automatically highlights suspicious areas on computerized tomography (CT) scans of the colon, helping radiologists to identify, measure and analyze potential disease and early indicators of disease. Medicsight's CAD software has been validated using one of the world's largest and most population diverse databases of verified patient CT scan data. Medicsight's ColonCAD software products are seamlessly integrated with the advanced 3D visualization workstations of several industry-leading imaging equipment partners.

The Company holds 54.0% of the outstanding shares of Medicsight Ltd.

Recent Releases

Jan 12, 2012
MGT Names Robert Ladd as President and Chief Executive Officer

Jan 9, 2012
MGT Capital Investments, Inc.: Failure to Satisfy a Continued Listing Rule Based on a Lack of Shareholder Meeting in 2011

more »


 


Privacy Policy

 http://www.mgtci.com
  © Copyright 2012 MGT Capital Investments, Inc.